Christina Ullrich

Christina Ullrich


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
CUChristina Ullrich
Christina Ullrich
LLLeslie Lehmann
Leslie Lehmann
WLWendy B. London
Wendy B. London
DGDongjing Guo
Dongjing Guo
MSMadhumitha Sridharan
Madhumitha Sridharan
JWJoanne Wolfe
Joanne Wolfe
Stem cell transplantation (SCT) is an intensive therapy offering the possibility of cure for life-threatening conditions but with risk of serious complications and death. Outcomes associated with pediatric palliative care (PPC) for children who undergo SCT are unknown. Therefore, we evaluated whether PPC consultation is associated with differences in end-of-life (EOL) care patterns for children who underwent SCT and did not survive. Medical records of children who underwent SCT at Boston Children's Hospital/Dana-Farber Cancer Institute for any indication from September 2004 to December 2012 and did not survive were reviewed. Child demographic and clinical characteristics and PPC consultation and EOL care patterns were abstracted. Children who received PPC (PPC group) were compared with those who did not (non-PPC group). Children who received PPC consultation (n = 37) did not differ from the non-PPC group (n = 110) with respect to demographic or clinical characteristics, except they were more likely to have undergone unrelated allogeneic SCT (PPC, 68%; non-PPC, 39%; P = .02) or to have died from treatment-related toxicity (PPC, 76%; non-PPC, 54%; P = .03). PPC consultation occurred at a median of .7 months (interquartile range [IQR], .4 to 4.2) before death. PPC consultations most commonly addressed goals of care/decision-making (92%), psychosocial support (84%), pain management (65%), and non-pain symptom management (70%). Prognosis discussions (ie, the likelihood of survival) occurred more commonly in the PPC group (PPC, 97%; non-PPC, 83%; P = .04), as did resuscitation status discussions (PPC, 88%; non-PPC, 58%; P = .002). These discussions also occurred earlier in the PPC group, for prognosis a median of 8 days (IQR, 4 to 26) before death compared with 2 days (IQR, 1 to 13) in the non-PPC group and for resuscitation status a median of 7 days (IQR, 3 to 18) compared with 2 days (IQR, 1 to 5) in the non-PPC group (P < .001 for both of the timing of prognosis and resuscitation status discussions). The PPC group was also was more likely to have resuscitation status documented (PPC, 97%; non-PPC, 68%; P = .002). With respect to patterns of care, compared with non-PPC, the PPC group was as likely to die in a medicalized setting (ie, the hospital) (PPC, 84%; non-PPC, 77%; P = .06) or have hospice care (PPC, 22%; non-PPC, 18%; P = .6). However, among children who died in the hospital, those who received PPC were more likely to die outside the intensive care unit (PPC, 80%; non-PPC, 58%; P = .03). In addition, the PPC group was less likely to receive intervention-focused care such as intubation in the 24 hours before death (PPC, 42%; non-PPC, 66%; P = .02) or cardiopulmonary resuscitation (PPC, 3%; non-PPC, 20%; P = .03) at EOL. Children who received PPC for at least a month were more likely to receive hospice care (PPC, 41%; non-PPC, 5%; P = .01). Children who underwent SCT and did not survive were likely to die in a medicalized setting, irrespective of PPC. However, PPC was associated with less intervention-focused care and greater opportunity for EOL communication and advance preparation. In the intense, cure-oriented SCT setting, PPC may facilitate advance care planning in this high-risk population.

1 October 2010 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
CUChristina Ullrich
Christina Ullrich
VDVeronica Dussel
Veronica Dussel
JHJoanne M. Hilden
Joanne M. Hilden
JSJan W. Sheaffer
Jan W. Sheaffer
CMCaron L. Moore
Caron L. Moore
JWJoanne Wolfe
Joanne Wolfe

15 September 2018 in Cancer
Verified
Journal Article
Closed access
PDF file
CUChristina Ullrich
Christina Ullrich
VDVeronica Dussel
Veronica Dussel
LOLiliana Orellana
Liliana Orellana
TKTammy I. Kang
Tammy I. Kang
ARAbby R. Rosenberg
Abby R. Rosenberg
JWJoanne Wolfe
Joanne Wolfe

28 March 2018 in Children
Verified
Journal Article
Open access
PDF file
KBKatharine Brock
Katharine Brock
JWJoanne Wolfe
Joanne Wolfe
CUChristina Ullrich
Christina Ullrich
Despite vast improvements in disease-based treatments, many children live with life-threatening disorders that cause distressing symptoms. These symptoms can be difficult to comprehensively assess and manage. Yet, frequent and accurate symptom reporting and expert treatment is critical to preserving a patient’s physical, psychological, emotional, social, and existential heath. We describe emerging methods of symptom and health-related quality-of-life (HRQOL) assessment through patient-reported outcomes (PROs) tools now used in clinical practice and novel research studies. Computer-based and mobile apps can facilitate assessment of symptoms and HRQOL. These technologies can be used alone or combined with therapeutic strategies to improve symptoms and coping skills. We review technological advancements, including mobile apps and toys, that allow improved symptom reporting and management. Lastly, we explore the value of a pediatric palliative care interdisciplinary team and their role in assessing and managing distressing symptoms and minimizing suffering in both the child and family. These methods and tools highlight the way that novel, new, and innovative approaches to symptom assessment and management are changing the way that pediatrics and pediatric palliative care will be practiced in the future.

7 April 2017 in Cancer
Verified
Journal Article
Open access
PDF file
CUChristina Ullrich
Christina Ullrich
ARAngie Mae Rodday
Angie Mae Rodday
KBKristin M. Bingen
Kristin M. Bingen
MKMary Jo Kupst
Mary Jo Kupst
SPSunita K. Patel
Sunita K. Patel
SPSusan K. Parsons
Susan K. Parsons
BACKGROUND: The experience of children undergoing hematopoietic stem cell transplantation (HSCT), including the ways in which different participants (ie, children, parents, and nurses) contribute to the overall picture of a child's experience, is poorly characterized. This study evaluated parent, child, and nurse perspectives on the experience of children during HSCT and factors contributing to interrater differences.METHODS: Participants were enrolled in a multicenter, prospective study evaluating child and parent health‐related quality of life over the year after HSCT. Children (n = 165) and their parents and nurses completed the Behavioral, Affective, and Somatic Experiences Scale (BASES) at baseline (before/during conditioning), 7 days after the stem cell infusion (day+7), and 21 days after the stem cell infusion (day+21). The BASES domains included Somatic Distress, Mood Disturbance, Cooperation, and Getting Along. Higher scores indicated more distress/impairment. Repeated measures models by domain assessed differences by raters and changes over time and identified other factors associated with raters' scores.RESULTS: Completion rates were high (≥73% across times and raters). Multivariate models revealed significant time‐rater interactions, which varied by domain. For example, parent‐rated Somatic Distress scores increased from baseline to day+7 and remained elevated at day+21 (P< .001); children's scores were lower than parents' scores across time points. Nurses' baseline scores were lower than parents' baseline scores, although by day+21 they were similar. Older child age was associated with higher Somatic Distress and Mood Disturbance scores. Worse parent emotional functioning was associated with lower scores across raters and domains except for Cooperation.CONCLUSIONS: Multirater assessments are highly feasible during HSCT. Ratings differ by several factors; considering ratings in light of such factors may deepen our understanding of the child's experience.Cancer2017;123:3159–66.©2017 American Cancer Society.

1 October 2007 in Pediatric Clinics of North America
Verified
Journal Article
Closed access
CUChristina Ullrich
Christina Ullrich
OMOscar H. Mayer
Oscar H. Mayer